Atherosclerosis is a chronic inflammatory disease in which fatty deposits, immune cells, and fibrous tissue build up inside the walls of medium and large arteries, gradually narrowing them and sometimes triggering sudden blockages that cause heart attacks or strokes. It develops over decades, often without any symptoms until an artery is severely narrowed or a deposit ruptures. Because of that long silent phase, understanding the causes, the warning signs that do eventually appear, and the tools doctors use to catch it early matters more here than for almost any other cardiovascular condition.
What Actually Happens Inside the Artery Wall
Atherosclerosis is not simply “clogged pipes.” It begins with damage to the endothelium, the thin layer of cells lining every artery. High blood pressure, cigarette smoke, high blood sugar, and high levels of LDL cholesterol can all injure these cells. Once the endothelium is compromised, LDL particles slip into the artery wall and become chemically modified, primarily through oxidation. The body treats oxidized LDL as a threat and sends immune cells, particularly macrophages, to clean it up.
The cleanup backfires. Macrophages engulf oxidized LDL but struggle to process it and become bloated with lipids, transforming into what researchers call foam cells. This abnormal digestion of oxidized LDL and the resulting lipid accumulation are central to how atherosclerosis progresses.1PubMed Central. Modification macrophage to foam cells in atherosclerosis disease: some factors stimulate or inhibit this process Foam cells cluster together beneath the endothelium, forming a fatty streak visible under a microscope but invisible to the person living with it.
Inflammation drives the process at every stage. Pro-inflammatory signaling molecules accelerate the disease, while anti-inflammatory ones slow it down.2PubMed Central. The Role of Cytokines in the Development of Atherosclerosis This is why atherosclerosis is now understood as an inflammatory disease at its core, not merely a cholesterol-storage problem. The immune system’s ongoing, unresolved response to the artery wall injury is what turns a minor lipid deposit into a growing, dangerous plaque.
Why Certain Spots in Your Arteries Are More Vulnerable
Plaques do not form randomly. They cluster at branches, bends, and bifurcations where blood flow becomes turbulent rather than smooth. At these sites, the mechanical forces acting on the endothelium are irregular and complex, and those disturbed flow patterns predict where atherosclerosis will appear.3PubMed Central. Hemodynamic shear stress and the endothelium in cardiovascular pathophysiology In straight sections of arteries where blood flows steadily, the endothelium stays healthier and more resistant to LDL infiltration.4PubMed Central. Biophysical and Biochemical Roles of Shear Stress on Endothelium: A Revisit and New Insights
This explains a pattern that surprises many people: atherosclerosis is not evenly distributed. You can have severe plaque buildup in one coronary artery and almost none in the one next to it. The geometry of your blood vessels, including how sharply your arteries branch, plays a real role in where disease takes hold.
From Fatty Streak to Fibrous Plaque
A fatty streak is just the beginning. As the disease progresses, smooth muscle cells migrate from deeper layers of the artery wall toward the surface, where they produce a tough, fibrous cap over the growing lipid core.5PubMed Central. Mechanisms of fibrous cap formation in atherosclerosis Beneath that cap sits what pathologists call the necrotic core: a mix of dead cells, extracellular lipids, immune cells, and debris from macrophages that were never properly cleared away.6European Heart Journal. Smooth muscle cells in atherosclerosis: essential but overlooked translational perspectives
As plaques mature, calcium begins to deposit within them. The earliest calcifications are tiny, measuring less than 15 micrometers. Over time, some plaques develop dense, sheet-like calcification, and somewhat counterintuitively, those heavily calcified plaques tend to be more stable. It is the small, scattered, fragmented calcium deposits that are more often associated with early-stage or unstable lesions prone to rupturing.7PubMed. Calcium deposition within coronary atherosclerotic lesion: Implications for plaque stability This is why a coronary calcium scan showing heavy calcification is not necessarily the worst news: it signals disease is present, but the plaques may be relatively stable.
Major Causes and Risk Factors
Atherosclerosis results from a combination of modifiable and non-modifiable risk factors. The modifiable ones are where prevention efforts focus, because changing them genuinely slows the disease.
- High blood pressure: Considered the most widespread modifiable risk factor for atherosclerosis, chronic high blood pressure damages the endothelium through direct mechanical stress and triggers inflammation, oxidative stress, and vascular remodeling that makes arteries stiffer and more vulnerable to plaque formation.8PubMed Central. Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment 9PubMed Central. Arterial stiffness and hypertension High blood pressure also creates oxidative stress on the artery wall that amplifies the damage caused by other risk factors like high cholesterol.10PubMed. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective
- High LDL cholesterol: Elevated LDL provides more raw material for oxidized LDL to accumulate in artery walls. Some people carry inherited genetic variants that keep their LDL dangerously high from birth. In one large study, more than 90% of monogenic familial hypercholesterolemia cases involved mutations in the LDLR gene, which encodes the receptor responsible for clearing LDL from the bloodstream.11JAMA Cardiology. Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease
- Diabetes and high blood sugar: Chronic hyperglycemia chemically modifies proteins and lipids through a process called glycation, which disrupts their normal function. These glycated molecules interact with receptors on macrophages, endothelial cells, and smooth muscle cells, inducing oxidative stress and pro-inflammatory responses that accelerate atherosclerosis.12PubMed Central. How hyperglycemia promotes atherosclerosis: molecular mechanisms
- Smoking: Tobacco smoke damages the endothelium directly, promotes oxidation of LDL, and increases blood clotting tendency.
- Age and genetics: The disease progresses with time regardless of lifestyle, and family history of early heart disease raises your risk substantially. These are factors you cannot change, but they inform how aggressively the modifiable ones should be managed.
A Disease That Hides for Decades
The most unsettling thing about atherosclerosis is how long it stays invisible. Early subclinical disease produces no symptoms at all. Arteries have enough reserve capacity that even moderate narrowing often goes unnoticed. Long-running studies tracking apparently healthy middle-aged people have shown that atherosclerosis can be detected years or even decades before any symptoms appear, progressing silently through stages that are only visible with advanced imaging.13PubMed. Progression of Early Subclinical Atherosclerosis (PESA) Study: JACC Focus Seminar 7/8
When symptoms do appear, they reflect which arteries are affected. Narrowing in the coronary arteries causes chest pain or tightness during exertion, known as angina. Narrowing in the carotid arteries supplying the brain can cause transient ischemic attacks, brief episodes of weakness, slurred speech, or vision changes that resolve within hours. In the legs, reduced blood flow causes cramping or pain when walking, called claudication. In some people, the first symptom is a catastrophic event: a heart attack, stroke, or sudden cardiac death.
The progression from early, uncomplicated plaque to a dangerous lesion capable of rupturing is not inevitable, but plaque progression is considered a necessary step between the early disease and the acute events people fear most.14PubMed. From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events: JACC State-of-the-Art Review That gradual worsening is the window during which detection and treatment can change outcomes.
Sex Differences in Atherosclerosis
Atherosclerosis does not behave identically in men and women, and the differences go beyond the familiar observation that women tend to develop heart disease about a decade later than men. Across imaging and autopsy studies, overall plaque burden and markers of inflammation appear greater in men than in women, and these markers predict cardiovascular events.15PubMed Central. Sex as a Biological Variable in Atherosclerosis However, the protection women experience at younger ages fades dramatically with time. By the seventh decade, the incidence of heart attacks in women actually surpasses that in men, suggesting that sex and age interact in ways that are not fully understood.
The type of plaque event also differs. Plaque erosion, where a blood clot forms on an intact plaque surface rather than through a rupture, is more commonly seen in younger women who smoke. Plaque rupture, the more classically described mechanism, is more common in older women and in men with elevated cholesterol.16PubMed. Sex Differences in Coronary Atherosclerosis Traditional risk factors also contribute differently between the sexes, and women face female-specific risk factors, including pregnancy complications like preeclampsia, that influence later cardiovascular risk. Coronary artery calcification patterns differ as well, complicating how calcium scores should be interpreted across sexes.
How Atherosclerosis Is Diagnosed
Because the disease is silent for so long, diagnosis often starts with risk assessment rather than symptom investigation. Doctors use a combination of blood tests, risk calculators, and imaging to detect and quantify the disease.
Blood work forms the baseline. A standard lipid panel measures LDL, HDL, and triglycerides. C-reactive protein, a marker of systemic inflammation, provides an additional window: elevated CRP levels have been independently linked to higher plaque burden in the coronary arteries, even after accounting for traditional risk factors.17The American Journal of Cardiology. Relation of C-Reactive Protein to Coronary Plaque Characteristics on Grayscale, Radiofrequency Intravascular Ultrasound, and Cardiovascular Outcome in Patients With Acute Coronary Syndrome or Stable Angina Pectoris Blood tests alone cannot tell you whether you have atherosclerosis, but they identify the metabolic environment that feeds it.
The coronary artery calcium score is one of the most widely used non-invasive imaging tests for detecting subclinical atherosclerosis. It uses a quick CT scan to quantify the amount of calcium deposited in the coronary artery walls. The calcium score correlates closely with overall atherosclerotic burden.18PubMed. Role of coronary artery calcium score and coronary CT angiography in the diagnosis and risk stratification of individuals with suspected coronary artery disease A score of zero in a middle-aged adult is reassuring, though it does not rule out non-calcified plaque. Higher scores prompt more aggressive prevention strategies and sometimes additional testing.
Coronary CT angiography goes further, using contrast dye to visualize both calcified and non-calcified plaques as well as the degree of artery narrowing. For patients who are symptomatic or at high risk, this test provides a detailed map of where and how severely the arteries are affected.
In more specialized settings, intravascular ultrasound provides direct visualization of plaque from inside the artery. A tiny ultrasound probe is threaded into the coronary artery during a catheterization, allowing doctors to see the plaque’s size, composition, and vulnerability features that external imaging might miss.19PubMed Central. Inflammation, plaque progression and vulnerability: evidence from intravascular ultrasound imaging This is not a screening tool for the general population, but it is valuable for guiding treatment decisions in patients already undergoing cardiac catheterization.
When a Plaque Becomes Dangerous
The most feared consequence of atherosclerosis is not the gradual narrowing of an artery. It is the sudden rupture of a plaque. When a plaque’s fibrous cap becomes thin enough, it can tear open, exposing the lipid-rich necrotic core to the bloodstream. The body treats this as a wound and immediately forms a blood clot. If that clot is large enough to block the artery, the tissue downstream loses its blood supply. In a coronary artery, that is a heart attack. In an artery feeding the brain, it is a stroke.
Most plaque ruptures occur in lesions called thin-cap fibroatheromas, where the fibrous cap has been weakened by enzymes that degrade its structural proteins and by a loss of the smooth muscle cells that maintain it.20PubMed. Mechanisms of plaque formation and rupture Immune cells within the plaque actively contribute to this thinning: activated T cells can inhibit the production of new structural material, making the cap progressively more fragile.21PubMed. Mechanisms of plaque vulnerability and rupture
Not all acute events involve rupture, though. Some clots form on plaques whose surface has eroded without a frank tear, a mechanism called plaque erosion. The underlying causes of erosion remain less well understood, though coronary artery spasm is suspected to play a role. Once a plaque surface is disrupted by either mechanism, the exposed material activates the clotting cascade and recruits platelets, leading to rapid thrombus formation that can partially or completely block blood flow.22PubMed. Thrombosis formation on atherosclerotic lesions and plaque rupture
A critical point here is that the plaques most likely to rupture are often not the ones causing the most narrowing. A plaque blocking 40% of an artery might have a thin, inflamed cap sitting over a large lipid pool, making it far more dangerous than a heavily calcified plaque blocking 80% of a different artery. This is why someone can have a normal stress test and still have a heart attack weeks later: stress tests detect flow-limiting narrowing, not plaque vulnerability.
Atherosclerosis vs. Other Artery Diseases
The terms “arteriosclerosis” and “atherosclerosis” are frequently used interchangeably in conversation, but they are not the same thing. Arteriosclerosis is a broader term for stiffening and loss of elasticity in the artery wall from any cause. Atherosclerosis is a specific type of arteriosclerosis driven by inflammatory lesions in the inner layer of the artery and characterized by lipid-rich plaque that can obstruct blood flow.23PubMed Central. Arteriosclerosis, atherosclerosis, arteriolosclerosis, and Monckeberg medial calcific sclerosis: what is the difference?
Two other conditions fall under the arteriosclerosis umbrella but differ from atherosclerosis in important ways. Arteriolosclerosis involves thickening of tiny arterioles, particularly in people with chronic high blood pressure, and mainly affects organs like the kidneys and brain. Mönckeberg medial calcific sclerosis causes calcium deposits in the muscular layer of artery walls but does not obstruct the vessel’s interior. A person with Mönckeberg disease may have strikingly abnormal imaging studies, with arteries that look calcified on an X-ray, yet have no actual blockages. Recognizing these distinctions matters because the treatment implications are different.
The Lipid-Lowering and Plaque-Stabilization Connection
Much of modern atherosclerosis treatment centers on lowering LDL cholesterol, and the evidence supports this approach for reasons beyond just shrinking plaque. Lipid-lowering therapy appears to stabilize plaques in two distinct ways: it reduces the size of the lipid core, and it allows the fibrous cap to thicken.24PubMed Central. PCSK9 and Coronary Artery Plaque—New Opportunity or Red Herring? Both changes make a plaque less likely to rupture. In other words, the cardiovascular benefit of lowering cholesterol is not only about making plaques smaller. Even if a plaque stays roughly the same size, converting it from a vulnerable, inflamed lesion with a thin cap into a more fibrous, stable one reduces the risk of an acute event. This reframing has shifted how cardiologists think about treatment goals, from regression alone to a combination of regression and stabilization.
Emerging Areas of Research
Two areas of recent research have expanded the picture of what drives atherosclerosis beyond the classic risk factors. The gut microbiome is one. Multiple studies now show that bacteria in the intestines produce metabolites that influence cardiovascular inflammation, with trimethylamine N-oxide, or TMAO, being the most studied. Researchers have proposed a feed-forward loop in which certain gut bacteria generate TMAO, which in turn activates inflammatory pathways in the vessel wall, and that the process may be amplified by age-related mutations in blood-forming stem cells, a phenomenon known as clonal hematopoiesis.25PubMed Central. Clonal Hematopoiesis and Gut Microbiota-Derived TMAO as Candidate Amplifiers of Cardiovascular Inflammation: The CHIDT Hypothesis This is still hypothesis-stage work, but the gut microbiome is increasingly recognized as a potential intervention target for atherosclerosis.26PubMed Central. Impact of the gut microbiome on atherosclerosis
The second frontier involves circadian rhythms. Disrupted or misaligned internal clocks, the kind caused by chronic shift work, jet lag, or poor sleep schedules, promote both metabolic and inflammatory pathologies. Data from both human and animal studies show that an impaired internal clock, disturbed sleep, and shifting light-dark patterns alter how immune cells and lipids circulate in the blood and change how cells behave inside atherosclerotic plaques.27PubMed Central. Circadian Influence on Metabolism and Inflammation in Atherosclerosis This line of research suggests that when you eat and sleep may matter for atherosclerosis risk, not just what you eat and how much you exercise.
Atherosclerosis in the Ancient World
One of the more surprising findings in cardiovascular research is that atherosclerosis is not a product of modern lifestyles. CT scans of ancient Egyptian mummies found definite or probable atherosclerosis in roughly half of those with identifiable cardiovascular structures, spanning more than 2,000 years of Egyptian history.28PubMed. Atherosclerosis in ancient Egyptian mummies: the Horus study A follow-up study expanded the search to mummies from four geographically and culturally distinct preindustrial populations, including pre-agricultural hunter-gatherers, and found atherosclerosis was common across all of them.29The Lancet. Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations
Additional mummy studies, including examinations of an 18th-century Aleutian mummy, Italian Renaissance remains, and a 17th-century Korean mummy, have confirmed that atherosclerosis and coronary artery disease were not rare in premodern populations.30PLOS ONE. Paleogenetic study on the 17th century Korean mummy with atherosclerotic cardiovascular disease These findings raise the possibility that humans carry a basic biological predisposition to atherosclerosis, and that modern risk factors like smoking, processed food, and sedentary living accelerate an already inherent vulnerability rather than creating the disease from scratch. It is a humbling corrective to the assumption that if we could just live more “naturally,” atherosclerosis would vanish.